Evidence map›Paper›PMID 31268597›Full record

ArticleThe EMBO journal2019

The N-end rule ubiquitin ligase UBR2 mediates NLRP1B inflammasome activation by anthrax lethal toxin.

Hao Xu, Jianjin Shi, Hang Gao, Ying Liu, Zhenxiao Yang, Feng Shao, Na Dong

Open access · bronzeAbstract read
In one paragraph

Article in The EMBO journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed, 1 pooled it
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 1 synthesis or guideline pooled it, 100 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. N-degron pathways.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Review
  10. Mechanistic insights from inflammasome structures.Nature reviews. Immunology · 2024
    Review
  11. Review
  12. Review
  13. NLRP inflammasomes in health and disease.Molecular biomedicine · 2024
    Review
  14. Review
  15. The gasdermin family: emerging therapeutic targets in diseases.Signal transduction and targeted therapy · 2024
    Review
  16. Article
  17. Article
  18. Regulation of the Inflammasome Activation by Ubiquitination Machinery.Advances in experimental medicine and biology · 2024
    Review
  19. Review
  20. Article

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Hao XuNational Institute of Biological Sciences, Beijing, China.
Jianjin ShiNational Institute of Biological Sciences, Beijing, China.
Hang GaoState Key Laboratory of Animal Nutrition, College of Animal Science and Technology, China Agricultural University, Beijing, China.
Ying LiuState Key Laboratory of Animal Nutrition, College of Animal Science and Technology, China Agricultural University, Beijing, China.
Zhenxiao YangNational Institute of Biological Sciences, Beijing, China.
Feng ShaoNational Institute of Biological Sciences, Beijing, China.ORCID 0000-0002-9562-7791
Na DongNational Institute of Biological Sciences, Beijing, China.ORCID 0000-0003-2093-4719
National Institute of Biological Sciences, Beijing · CNChina Agricultural University · CN

Funding

CAS | Chinese Academy of Sciences Key Project (CAS Key Project) XDB08020202Ministry of Science and Technology of the People's Republic of China (MOST) 2016YFA0501500Ministry of Science and Technology of the People's Republic of China (MOST) 2017YFA0505900National Natural Science Foundation of China (NSFC) 81671987National Natural Science Foundation of China (NSFC) 81788104
6 · The paper itself

Abstract

Anthrax lethal toxin (LT) is known to induce NLRP1B inflammasome activation and pyroptotic cell death in macrophages from certain mouse strains in its metalloprotease activity-dependent manner, but the underlying mechanism is unknown. Here, we establish a simple but robust cell system bearing dual-fluorescence reporters for LT-induced ASC specks formation and pyroptotic lysis. A genome-wide siRNA screen and a CRISPR-Cas9 knockout screen were applied to this system for identifying genes involved in LT-induced inflammasome activation. UBR2, an E3 ubiquitin ligase of the N-end rule degradation pathway, was found to be required for LT-induced NLRP1B inflammasome activation. LT is known to cleave NLRP1B after Lys44. The cleaved NLRP1B, bearing an N-terminal leucine, was targeted by UBR2-mediated ubiquitination and degradation. UBR2 partnered with an E2 ubiquitin-conjugating enzyme UBE2O in this process. NLRP1B underwent constitutive autocleavage before the C-terminal CARD domain. UBR2-mediated degradation of LT-cleaved NLRP1B thus triggered release of the noncovalent-bound CARD domain for subsequent caspase-1 activation. Our study illustrates a unique mode of inflammasome activation in cytosolic defense against bacterial insults.

Indexed as

AnimalsAntigens, BacterialApoptosis Regulatory ProteinsBacterial ToxinsCaspase 1CRISPR-Cas SystemsGene Knockout TechniquesHEK293 CellsHumansInflammasomesMacrophagesMiceProtein DomainsProteolysisRAW 264.7 CellsRNA, Small Interferinganthrax toxinAntigens, BacterialApoptosis Regulatory ProteinsBacterial ToxinsCaspase 1InflammasomesRNA, Small InterferingUbiquitin-Conjugating EnzymesUbiquitin-Protein Ligasesanthrax lethal toxinN-end rule pathwayNLRP1B inflammasomeUBR2

Identifiers

PMID31268597
PMCPMC6600268
OpenAlexW2944219803

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.